Assessment of Eloquent Function in Brain Tumor Patients

Part of paid clinical trials in Omaha, Nebraska.

Sponsor
University of Nebraska
Study ID
NCT01535430
Status
Recruiting
Apply to this trial

Conditions

  • Metastatic Brain Tumor
  • Primary Brain Tumor

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Brain mapping — DIAGNOSTIC_TEST
    Brain mapping will be employed pre-, intra-, and post-operatively to evaluate specific functions.

Study Details

Purpose of the study: AIM 1: Prospectively collect pre-operative \[functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), magnetoencephalography (MEG)\] and intra-operative mapping data in patients with intra-axial brain tumors to assess how well each modality predicts the location of eloquent brain function. In addition, each modality will be compared with the other. AIM 2: Assess reorganization of eloquent brain function and plasticity in patients with intra-axial brain tumors. This will be accomplished by prospectively collecting post-operative mapping studies and neuropsychological tests to compare them to prior mapping studies as stated above.

Key Dates

Start date
Jan 31, 2012
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
75 participants (estimated)

Arms

  • Arm: Eloquent area tumor
    Standard of care with brain mapping, pre-, intra-, and post-operative.

Primary Outcome Measure

Eloquent function [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Nebraska Medical CenterOmahaNebraska68198
Dulce Maroni, PhD
[email protected]
402-836-9751
Katie Maire, MS
[email protected]
402-559-6895
Michele Aizenberg, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Omaha, NE

By research site
University of Nebraska Medical Center· Omaha, NE

Related Studies